Nu Skin Enterprises (NYSE:NUS) Releases FY 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2026 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.550-0.650 for the period, compared to the consensus earnings per share estimate of 0.820. The company issued revenue guidance of $1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Nu Skin Enterprises Stock Performance

NYSE NUS traded down $0.21 during trading on Friday, hitting $4.32. 297,247 shares of the company’s stock traded hands, compared to its average volume of 573,282. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.24 and a current ratio of 1.98. The stock has a market capitalization of $210.28 million, a price-to-earnings ratio of -0.97 and a beta of 0.92. Nu Skin Enterprises has a 12-month low of $4.24 and a 12-month high of $11.67. The business has a 50 day moving average of $4.77 and a 200-day moving average of $6.30.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Friday, November 6th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.11). Nu Skin Enterprises had a positive return on equity of 6.58% and a negative net margin of 15.73%. The business had revenue of $311.01 million during the quarter, compared to analysts’ expectations of $328.70 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.550-0.650 EPS. As a group, equities research analysts anticipate that Nu Skin Enterprises will post 0.82 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 9th. Investors of record on Friday, November 27th will be paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 5.6%. The ex-dividend date is Friday, November 27th. Nu Skin Enterprises’s payout ratio is currently -5.37%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on NUS shares. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, October 12th. Weiss Ratings cut Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce”.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.